Half-Match transplant vs. strong drugs: new hope for bone marrow failure
NCT ID NCT07338422
Summary
This study aims to find out which first treatment works better for severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. It will compare a stem cell transplant from a half-matched family donor to a course of powerful drugs that suppress the immune system. Doctors will assign patients aged 14-70 to one of these treatments based on their specific situation and preferences, then track their health outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.